About Mahatma Gandhi Cancer Hospital & Research Institute
"We are very highly trusted Cancer Hospital in this region. Recognised by the Government and as well as private organisations as having the latest Cancer-Care specialities in the state of Andhra Pradesh, in fact in this region itself."
Clinical Trials at Mahatma Gandhi Cancer Hospital & Research Institute
During the past decade, Mahatma Gandhi Cancer Hospital & Research Institute conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Mahatma Gandhi Cancer Hospital & Research Institute"
#1 collaborator was "Lambda Therapeutic Research Ltd." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Mahatma Gandhi Cancer Hospital & Research Institute
According to Clinical.Site data, the most researched conditions in "Mahatma Gandhi Cancer Hospital & Research Institute" are
"Advanced Prostate Cancer" (1 trials), "Breast Cancer" (1 trials) and "Ovarian Cancer Recurrent" (1 trials). Many other conditions were trialed in "Mahatma Gandhi Cancer Hospital & Research Institute" in a lesser frequency.
Clinical Trials Intervention Types at Mahatma Gandhi Cancer Hospital & Research Institute
Most popular intervention types in "Mahatma Gandhi Cancer Hospital & Research Institute" are "Drug" (3 trials). Other intervention types were less common.
The name of intervention was led by "Doxorubicin Hydrochloride Liposome Injection" (1 trials), "Goserelin acetate 3.6 mg Injection" (1 trials), "Inj. Goserelin (Test) Subcutaneously" (1 trials), "Inj. Zoladex (Reference) Subcutaneously" (1 trials) and "ZOLADEX® 3.6mg Injection" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Mahatma Gandhi Cancer Hospital & Research Institute
The vast majority of trials in "Mahatma Gandhi Cancer Hospital & Research Institute" are
2 trials for "Female" genders and 1 trials for "Male" genders.
Clinical Trials Status at Mahatma Gandhi Cancer Hospital & Research Institute
Currently, there are NaN active trials in "Mahatma Gandhi Cancer Hospital & Research Institute".
undefined are not yet recruiting,
2 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Mahatma Gandhi Cancer Hospital & Research Institute,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Mahatma Gandhi Cancer Hospital & Research Institute, 1 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".